Search Results - Simone Claudiani

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations by Simone Claudiani, Jane F. Apperley, Afzal Khan, Jamshid Khorashad, Dragana Milojkovic

    Published in Haematologica (2020-05-01)
    Get full text
    Article


  2. 2

    Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia by Fiona Fernando, Claudia Wasko, Bronwen Johns, Simone Claudiani, Afzal Khan, Andrew J. Innes, Dragana Milojkovic, Jane F. Apperley

    Published in eJHaem (2025-10-01)
    Get full text
    Article


  3. 3

    Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center by Giulia Simini, Andrew Innes, Saravanan Vinayagam, Golzar Mobayen, Nilanthi Karawitage, Simone Claudiani, Zain Odho, Mike Laffan, Deepa J. Arachchillage

    Get full text
    Article


  4. 4

    E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy by Simone Claudiani, Jane F. Apperley, Robert Peter Gale, Richard Clark, Richard Szydlo, Simona Deplano, Renuka Palanicawandar, Jamshid Khorashad, Letizia Foroni, Dragana Milojkovic

    Published in Haematologica (2017-08-01)
    Get full text
    Article


  5. 5

    MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia by Simone Claudiani, Aoife Gatenby, Richard Szydlo, George Nesr, Adi Shacham Abulafia, Renuka Palanicawandar, Georgios Nteliopoulos, Jamshid Khorashad, Letizia Foroni, Jane F. Apperley, Dragana Milojkovic

    Published in Haematologica (2019-11-01)
    Get full text
    Article


  6. 6

    FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions by Philippa C. May, Alistair G. Reid, Mark E. Robinson, Jamshid S. Khorashad, Dragana Milojkovic, Simone Claudiani, Genomics England Research Consortium, Fenella Willis, Jane F. Apperley, Andrew J. Innes

    Published in BMC Medical Genomics (2023-07-01)
    Get full text
    Article


  7. 7

    Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score by Fiona Fernando, Maria Sol Andres, Simone Claudiani, Nazanin Zounemat Kermani, Giulia Ceccarelli, Andrew J. Innes, Afzal Khan, Stuart D. Rosen, Jane F. Apperley, Alexander R. Lyon, Dragana Milojkovic

    Published in Cardio-Oncology (2024-07-01)
    Get full text
    Article


  8. 8

    Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors by Georgios Nteliopoulos, Alexandra Bazeos, Simone Claudiani, Gareth Gerrard, Edward Curry, Richard Szydlo, Mary Alikian, Hui En Foong, Zacharoula Nikolakopoulou, Sandra Loaiza, Jamshid S. Khorashad, Dragana Milojkovic, Danilo Perrotti, Robert Peter Gale, Letizia Foroni, Jane F. Apperley

    Published in Haematologica (2019-12-01)
    Get full text
    Article


Search Tools: